Analysis of heart rate variability in hypertensive patients before and after treatment with angiotensin II-converting enzyme inhibitors;Análise da variabilidade da freqüência cardíaca em pacientes hipertensos, antes e depois do tratamento com inibidores da enzima conversora da angiotensina II

Arquivos Brasileiros de Cardiologia

Volumn 83, Issue 2, 2004, Pages 165-172

  Da Silva Menezes Jr , Antônio ^a,b   Graner Moreira, Humberto ^a,b   Tavares Daher, Murilo ^a,b  

^a Hospital Sao Francisco de Assis ^*  (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

ACE inhibitors; Arterial hypertension; Autonomic nervous system; Heart rate variability

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; RAMIPRIL;

ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM; DIASTOLIC BLOOD PRESSURE; ELECTROCARDIOGRAPHY MONITORING; ENZYME INHIBITION; FEMALE; HEART RATE; HOLTER MONITORING; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RR INTERVAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 4344702481     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0066-782x2004001400008     Document Type: Article

References (37)

1. Julius S. Autonomic nervous system dysregulation in human hypertension. Am J Cardiol 1991; 67: 3B-7B.
2. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Eur Heart J 1996; 17: 354-81.
3. Malik M, Camm AJ. Components of heart rate variability - What they really mean and what we really measure. Am J Cardiol 1993; 72: 821-2.
4. Furlan R, Guzetti S, Crivellaro W et al. Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects. Circulation 1990; 81: 537-47.
5. Guzzetti S, Dassi S, Pecis M et al. Altered pattern of circardian neural control of heart period in mild hypertension. J Hypertens 1991; 9: 831-8.
6. Langewitz W, Ruddel H, Schachinger H. Reduced parasympathetic cardiac control in patients with hypertension at rest and under mental stress. Am Heart J 1994; 127: 122-8.
7. Guzzetti S, Piccaluga E, Casati R et al. Sympathetic predominance in essential hypertension: a study employing spectral analysis of heart rate variability. J Hypertens 1988; 6: 711-7.
8. Piccirilo G, Munizzi MR, Fimognari FL et al. Heart rate variability in hypertensive subjects. Int J Cardiol 1996; 53: 291-8.
9. Pikkujamsa SM, Huikuri HV, Airaksinen KE et al. Heart rate variability and baroreflex sensitivity in hypertensive subjects with and without metabolic features of insulin resistance syndrome. Am J Hypertens 1998; 11: 523-31.
10. Watkins LL, Grossman P, Sherwood A. Noninvasive assessment of baroreflex control in borderline hypertension: comparison with the phenylephrine method. Hypertension 1996; 28: 238-43.
11. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Mancia G. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension 1998; 31: 68-72.
12. Mancia G, Ludbrook J, Ferrari A et al. Baroreceptor reflex in human hipertension. Circ Res 1978; 43: 170-7.
13. Mancia G, Ferraria A, Gregorini L et al. Control of blood pressure by carotid sinus baroreceptor in human beings. Am J Cardiol 1979; 44: 895-902.
14. Grassi G, Mancia G. Arterial baroreflexes and other cardiovascular reflexes in hypertension: In Guyton AC, Hall JE, Cardiovascular Physiology IV. Baltimore, University Park Press, 119, 1992.
15. Huikuri HV, Yitalo A, Pikkujämsä SM. Heart rate variability in systemic hypertension. Am J Cardiol 1996; 77: 1073-77.
16. Yitalo A, Airaksinem KEJ, Sellin L et al. Effects of combination antihypertensive therapy on baroreflex sensitivity and heart rate variability in systemic hypertension. Am J Cardiol 1999, 83: 885-9.
17. Sociedade Brasileira de Hipertensão Arterial, Sociedade Brasileira de Cardiologia, Sociedade Brasileira de Nefrologia. IV Diretrizes Brasileiras de Hipertensão Arterial. Campos do Jordão, fev 2002.
18. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC). The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-72.
19. Barbosa FJ, Barbosa PRB, Cordovil I. Modulação autonômica do coraçâo na hipertensão arterial sistêmica. Arq Bras Cardiol 2002; 78: 181-8.
20. Chakko S, Mulingtapang RF, Huikuri HV, Kessler KM, Materson BJ, Myerburg RJ. Alterations in heart rate variability and its circadian rhythm in hypertensive patients with left ventricular hypertrophy free of coronary artery disease. Am Heart J 1993; 126: 1364-72.
21. Singh JP, Larson MG, Tsuji H, Evans JC, O'Donnell CJ, Levy D. Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham heart study. Hypertension 1998; 32: 293-7.
22. Sevre K, Lefrandt JD, Nordby G et al. Autonomic Function in hypertensive and normotensive subjects. The importance of gender. Hypertension 2001; 37: 1351-6.
23. Bigger JT Jr, Fleiss JL, Steinmann RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992; 85: 164-71.
24. Woolert KC, Drexler H. The rennin-angiotensin system and experimental heart failure. Cardiovasc Res 1995, 43: 838-49.
25. Lumbers ER, McCloskey DI, Potter EK. Inhibition by angiotensin II of baroreceptor-evoked activity in cardiac vagal efferent nerves in the dog. J Physiol 1979; 294: 69-80.
26. Phillips MI. New evidence for brain angiotensin and for its role in hypertension. Federation Proceedings 1983; 42: 2667-72.
27. Bickerton RK, Buckley JP. Evidence for a central mechanism of angiotensin induced hypertension. Proc Soc Exp Biol Med 1961; 106: 834-6.
28. Hoechst AG. Effects of angiotensin II and ACE inhibitors on electrically stimulated noradrenaline release from superfused rat brain slices. Clin Exp Theory Practice 1984; A6: 1847-51.
29. Kohlmann Jr O, Bresnahan M, Gavras H. Central and peripheral indices of sympathetic activity after blood pressure lowering with enalapril (MK-421) or hydralazine in normotensive rats. Hypertension 1984; 6(2 Pt 2): 11-16.
30. Cody RJ, Franklin KW, Kluger J et al. Mechanisms governing the postural response and baroreceptor abnormalities in chronic congestive heart failure: effects of acute and long-term converting-enzyme inhibition. Circulation 1982; 66: 135-42.
31. Oibner-Ounlap ME, Smith ML, Kinugawa T et al. Enalapril at augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure. J Am Coll Cardiol 1996; 27: 358-64.
32. Guyton AC, Hall JE. Textbook of Medical Physiology, 9th ed. WB Saunders, 1996.
33. Regoli D, Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol Rev 1980; 32: 1-46.
34. Schaefer S, Valente RA, Laslett LJ et al. Cardiac reflex effects of intracoronary bradykinin in humans. J Invest Med 1996; 44: 160-7.
35. Uchilda Y, Murao S. Bradykinin-induced excitation of afferent cardiac sympathetic nerve fibers. Jpn Heart J 1974; 15: 84-91.
36. Staszewska-Barczak J, Ferreira SH, Vane JR. An excitatory nociceptive cardiac reflex elicited by bradykinin and potentiated by prostaglandins and myocardial ischaemia. Cardiovasc Res 1976; 10: 314-27.
37. Baker DG, Coleridge HM, Coleridge JCG et al. Search for a cardiac nociceptor: stimulation by bradykinin of sympathetic afferent nerve endings in the heart of the cat. J Physiol (Lond) 1980; 306: 519-36.